North America Continuous Glucose Monitoring Market 2034
The North America continuous glucose monitoring (CGM) market has been gaining strong momentum, supported by rising diabetes prevalence, technological innovation, and greater adoption of digital health solutions. According to Expert Market Research, the market was valued at USD 6.56 billion in 2024 and is projected to expand at a CAGR of 14.50% between 2025 and 2034, reaching USD 25.41 billion by 2034. With diabetes becoming a critical public health challenge across the United States and Canada, CGM devices are increasingly vital for effective disease management.
North America Continuous Glucose Monitoring Market Size
While continuous glucose monitoring is advancing rapidly, it is essential to understand its scale within the broader healthcare technology landscape. In North America, CGM adoption is primarily fueled by high diabetes incidence rates and favorable reimbursement frameworks, particularly in the United States. Furthermore, the introduction of minimally invasive sensors, AI-enabled analytics, and wireless connectivity has improved the accessibility and usability of CGM systems.
North America Continuous Glucose Monitoring Market Share
Market share in the CGM sector is largely concentrated among a few leading players, including Abbott, Dexcom, and Medtronic. Abbott’s FreeStyle Libre has gained dominance due to its affordability and ease of use, while Dexcom’s G6 and G7 systems are widely recognized for accuracy and seamless smartphone integration. Medtronic continues to strengthen its share through hybrid closed-loop insulin delivery systems.
By application, Type 2 diabetes patients form the largest consumer base due to rising prevalence in North America. In terms of end users, home healthcare has emerged as the dominant segment, reflecting the growing demand for remote monitoring and personalized diabetes management solutions.
North America Continuous Glucose Monitoring Market Growth & Trends
The North America CGM market is expanding rapidly due to several critical drivers:
- Rising diabetes burden: More than 38 million people in the U.S. live with diabetes, making CGM devices essential for daily management.
- Technological innovations: Advances in sensor accuracy, non-invasive technology, and integration with smartphones and wearables are driving adoption.
- Shift toward preventive care: Increasing focus on continuous, real-time monitoring rather than periodic blood glucose testing.
- Favorable policies: Reimbursement support for CGM devices in the U.S. Medicare program has widened patient access.
Future trends point toward AI-driven predictive alerts, greater interoperability with insulin pumps, and adoption among the pediatric population.
North America Continuous Glucose Monitoring Market Case Studies & News
Recent developments reflect how leading players are shaping the market landscape:
- Dexcom launched its G7 CGM system in the U.S. and Canada, offering a smaller, faster warm-up sensor with expanded compatibility.
- Abbott partnered with Bigfoot Biomedical to expand insulin delivery ecosystems, further integrating CGM into personalized treatment plans.
- Senseonics’ Eversense E3 has gained FDA approval, notable for its long-term implantable sensor that can last up to 6 months.
These examples highlight the convergence of biotech, software, and digital health ecosystems, creating more reliable and user-friendly devices.
Chart Your Course in the North America Continuous Glucose Monitoring Market!
Get the insights you need to grow with the market—a free report download is available now.
North America Continuous Glucose Monitoring Market Analysis
The North America CGM market is characterized by intense competition, rapid innovation, and growing demand across demographics. The United States dominates the regional market due to higher diabetes prevalence, strong insurance coverage, and advanced healthcare infrastructure. Canada, while smaller in scale, is experiencing increased adoption due to government initiatives promoting digital health solutions.
Regulatory frameworks, particularly FDA approvals, continue to shape the pace of product launches. Additionally, growing emphasis on patient-centric care and remote monitoring aligns CGM technology with the broader digital health transformation.
North America Continuous Glucose Monitoring Market Segmentation
- By Components
- Sensors
- Transmitters
- Receivers
- By Application
- Type 1 Diabetes
- Type 2 Diabetes
- Others
- By Age Group
- Adult Population
- Child Population
- By End User
- Hospitals & Clinics
- Home Healthcare
- Others
- By Country
- United States of America
- Canada
North America Continuous Glucose Monitoring Market Key Players
Key companies shaping the North America CGM market include:
- Abbott
- Dexcom, Inc.
- Medtronic PLC
- Senseonics, Inc.
- Byram Healthcare Centers, Inc.
- Hoffmann-La Roche Limited
These firms are investing heavily in R&D, AI integration, and partnerships, ensuring strong competition and rapid technological advancements.
Find More Reports
Osteoarthritis Therapeutics Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
